Teva Pharmaceuticals To Expand in Canada With $6M Grant
05/28/2010
"Teva's high potent product manufacturing facility expansion in Stouffville, Ontario will enable use to secure Canadian and export mandates for high-quality, value-priced generic medicines," said Barry Fishman, president and CEO of Teva Canada Limited. "This partnership with the Ontario government to construct an advanced manufacturing facility will increase Teva Canada's capabilities and capacity and allow us to retain and grow high-value jobs in Ontario."
The same day the expansion was announced, Ontario Premier Dalton McGuinty met with scientists from Israel's Weizman Institute of Science to discuss new partnership opportunities. Among the Institute's research are ways to eliminate famine.
"Teva Pharmaceuticals is a perfect example of the kind of partner we're looking for in Israel," McGuinty said.
Most Read
-
-
2019 Leading Metro Locations: Pacific and South-Atlantic Metros Dominate the List
Q4 2019
-
2019 Top States for Doing Business: Georgia Ranks #1 Sixth Year in a Row
Q3 2019
-
Site Selection 2020: The Importance of “Regional Depth” with Global Reach
Q3 2020
-
How are Uncertain Times Altering Company Location Strategies?
Q3 2020
-
A Heightened Focus on Reshoring
Q3 2020
-
34th Annual Corporate Survey & the 16th Annual Consultants Survey
Q1 2020